Cargando…
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model
IMPORTANCE: The age-based or “one-size-fits-all” breast screening approach does not take into account the individual variation in risk. Mammography screening reduces death from breast cancer at the cost of overdiagnosis. Identifying risk-stratified screening strategies with a more favorable ratio of...
Autores principales: | Pashayan, Nora, Morris, Steve, Gilbert, Fiona J., Pharoah, Paul D. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230256/ https://www.ncbi.nlm.nih.gov/pubmed/29978189 http://dx.doi.org/10.1001/jamaoncol.2018.1901 |
Ejemplares similares
-
Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer
por: Callender, Thomas, et al.
Publicado: (2021) -
Cost effectiveness of the NHS breast screening programme: life table model
por: Pharoah, Paul D P, et al.
Publicado: (2013) -
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
por: Callender, Tom, et al.
Publicado: (2019) -
The cost-effectiveness of risk-stratified breast cancer screening in the UK
por: Hill, Harry, et al.
Publicado: (2023) -
Do cancer risk and benefit–harm ratios influence women’s consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries
por: Rebitschek, Felix G., et al.
Publicado: (2019)